Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF Prophylaxis for FOLFIRI/Bevacizumab in UGT1A1*28 mCRC
NCT00541125Phase 2Completed
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Nov 2007
- Primary completion
- Sep 2013
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of filgrastim in neutropenia, sponsored by Fédération Francophone de Cancérologie Digestive. Started Nov 2007; status: completed.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT00541125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541125.